* Precludes FDA’s authority to remove additives that are nontoxic but contribute to the lure of the product.
Critics argue that the FDA should have full authority to remove all [[additives]] used in tobacco products regardless of their toxicity, since many non-toxic additives, like [[menthol ]] or smootheners, contribute to the product's appeal and thus reinforce exposure to other toxins found in tobacco.
Critics oppose a provision in the bill that mandates that the tobacco industry have representation on the oversight committee created by the bill. They argue that tobacco manufacturers should not be givenspecial access or authority to influence rules the government makes about the labeling, healthand safety regulations of tobacco products. They also claim that this provision would also make the United States noncompliant with one of the key articles in the [[World Health Organization]]'s [[Framework Convention on Tobacco Control]].
The bill would also preempt state and local regulation of tobacco products. Critics argue that the FDA should set minimum standards for regulation and that local and state health authorities should have the ability to implement stronger regulations if such regulations are deemed necessary to protect public health.<ref>Joel Nitzkin, David Cundiff, American Association of Public Health Physicians [http://www.aaphp.org/special/20070712%20FDATobAnalrvs.pdf AAPHP Full Analysis of Proposed FDA Tobacco Legislation], July 12, 2007.33 pp. Accessed March 5, 2009</ref>